Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer

Overview of attention for article published in Frontiers in immunology, January 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 10 X posts from 9 X users, with an upper bound of 36,124 followers.

New article: Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer https://t.co/smPSIYuSps #breastcancer #oncology https://t.co/SDdj6sj6el

🔥Hottest @FrontImmunol articles this week #3: Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer. Shi A-P et al. Read 👉 https://t.co/uVp9C3WXr9 #immunology #cancer #cancerimmunity #cancerimmunotherapy #immunecheckpoint

Just reading two review about Cd73 from the same journal.

RT @FrontImmunol: New Research: Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer: LAG3 is the most promising immune checkpoint next to…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.